269
Views
12
CrossRef citations to date
0
Altmetric
Letters to the Editor

Patients with therapy-related myelodysplastic syndromes and acute myeloid leukemia share genetic features but can be separated by blast counts and cytogenetic risk profiles into prognostically relevant subgroups

, , , , &
Pages 639-642 | Received 05 Apr 2012, Accepted 24 Jul 2012, Published online: 21 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sarah E. Fordham, Helen Marr & James M. Allan. (2013) Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication. Leukemia & Lymphoma 54:3, pages 447-448.
Read now

Articles from other publishers (11)

Miguel D. Cantu, Rashmi Kanagal-Shamanna, Sa A. Wang, Tapan Kadia, Carlos E. Bueso-Ramos, Sanjay S. Patel, Julia T. Geyer, Wayne Tam, Yazan Madanat, Peng Li, Tracy I. George, Meredith M. Nichols, Heesun J. Rogers, Yen-Chun Liu, Nidhi Aggarwal, Jason H. Kurzer, Danielle L.V. Maracaja, Eric D. Hsi, Feras Zaiem, Daniel Babu, Kathryn Foucar, Dorottya Laczko, Adam Bagg, Attilio Orazi, Daniel A. Arber, Robert P. Hasserjian & Olga K. Weinberg. (2023) Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO Precision Oncology:7.
Crossref
Hidehiro Itonaga, Michiko Kida, Atsushi Hamamura, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Yasunori Ueda, Keisuke Kataoka, Yuta Katayama, Shuichi Ota, Ken‐ichi Matsuoka, Tadakazu Kondo, Tetsuya Eto, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Miyazaki & Ken Ishiyama. (2022) Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis. Hematological Oncology 40:4, pages 752-762.
Crossref
Ram Vasudevan Nampoothiri & Auro Viswabandya. (2020) Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia. Indian Journal of Hematology and Blood Transfusion 37:4, pages 521-527.
Crossref
Rory M. Shallis, Julian J. Weiss, Nicole C. Deziel & Steven D. Gore. (2021) Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst. Blood Reviews 47, pages 100760.
Crossref
A. Kuendgen, M. Nomdedeu, H. Tuechler, G. Garcia-Manero, R. S. Komrokji, M. A. Sekeres, M. G. Della Porta, M. Cazzola, A. E. DeZern, G. J. Roboz, D. P. Steensma, A. A. Van de Loosdrecht, R. F. Schlenk, J. Grau, X. Calvo, S. Blum, A. Pereira, P. Valent, D. Costa, A. Giagounidis, B. Xicoy, H. Döhner, U. Platzbecker, C. Pedro, M. Lübbert, I. Oiartzabal, M. Díez-Campelo, M. T. Cedena, S. Machherndl-Spandl, M. López-Pavía, C. D. Baldus, M. Martinez-de-Sola, R. Stauder, B. Merchan, A. List, C. Ganster, T. Schroeder, M. T. Voso, M. Pfeilstöcker, H. Sill, B. Hildebrandt, J. Esteve, B. Nomdedeu, F. Cobo, R. Haas, F. Sole, U. Germing, P. L. Greenberg, D. Haase & G. Sanz. (2020) Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS. Leukemia 35:3, pages 835-849.
Crossref
Ram Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, Carol Chen, Zeyad Al-Shaibani, David Loach, Fotios V. Michelis, Dennis (Dong Hwan) Kim, Jonas Mattsson, Rajat Kumar, Jeffrey Howard Lipton & Auro Viswabandya. (2021) Predictors of outcomes of therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Hematology/Oncology and Stem Cell Therapy.
Crossref
Deepak Singhal, Li Yan A. Wee, Monika M. Kutyna, Rakchha Chhetri, Joel Geoghegan, Andreas W. Schreiber, Jinghua Feng, Paul P.-S. Wang, Milena Babic, Wendy T. Parker, Smita Hiwase, Suzanne Edwards, Sarah Moore, Susan Branford, Teodora Kuzmanovic, Nimit Singhal, Raghu Gowda, Anna L. Brown, Peer Arts, Luen B. To, Peter G. Bardy, Ian D. Lewis, Richard J. D’Andrea, Jaroslaw P. Maciejewski, Hamish S. Scott, Christopher N. Hahn & Devendra K. Hiwase. (2019) The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution. Leukemia 33:12, pages 2842-2853.
Crossref
Daniil F. Gluzman, Lilia M. Sklyarenko, Stella V. Koval, Nataliia K. Rodionova, Michael P. Zavelevich, Tetiana S. Ivanivskaya, Liudmyla Yu. Poludnenko & Nataliia I. Ukrainskaya. (2015) Myelodysplastic syndromes in Chernobyl clean-up workers. Annals of Hematology 94:10, pages 1639-1643.
Crossref
Arjen HG Cleven, Valentina Nardi, Chi Young Ok, Maitrayee Goswami, Paola Dal Cin, Zongli Zheng, A John Iafrate, Myrurgia A Abdul Hamid, Sa A Wang & Robert P Hasserjian. (2015) High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome. Modern Pathology 28:4, pages 552-563.
Crossref
Chi Young Ok, Keyur P. Patel, Guillermo Garcia-Manero, Mark J. Routbort, Bin Fu, Guilin Tang, Maitrayee Goswami, Rajesh Singh, Rashmi Kanagal-Shamanna, Sherry A. Pierce, Ken H. Young, Hagop M. Kantarjian, L. Jeffrey Medeiros, Rajyalakshmi Luthra & Sa A. Wang. (2015) Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Leukemia Research 39:3, pages 348-354.
Crossref
C Y Ok, R P Hasserjian, P S Fox, F Stingo, Z Zuo, K H Young, K Patel, L J Medeiros, G Garcia-Manero & S A Wang. (2013) Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia. Leukemia 28:1, pages 185-189.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.